Related Experiment Video
Updated: Jan 26, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
microRNA-4500 inhibits human glioma cell progression by targeting IGF2BP1
Zheng-Wei Li1, Min Xue2, Bing-Xin Zhu1
1Neurosurgery Department, Xuzhou Children's Hospital, Xuzhou Medical University, Xuzhou, China.
Abstract:
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) overexpression promotes glioma cell progression. The aim of the current study is to silence IGF2BP1 in glioma cells by the microRNA (miRNA) strategy. The bio-informatic analyses identified that microRNA-4500 (miR-4500) putatively targets 3'-UTR (3'-untranslated region) of IGF2BP1. In A172 cells and primary human glioma cells ectopic overexpression of the wild-type miR-4500 (but not the mutant form) downregulated IGF2BP1 and its target genes (Gli1, IGF2 and c-Myc). Functional studies show that ectopic miR-4500 overexpression inhibited glioma cell growth, survival, proliferation, migration and invasion. Conversely, in A172 cells miR-4500 inhibition, by a lentiviral construct, increased expression of IGF2BP1 and its targets, promoting cell survival, proliferation and migration. Furthermore, IGF2BP1 knockout by the CRISPR/Cas9 method inhibited A172 cell progression. Significantly, miR-4500 overexpression or miR-4500 inhibition was ineffective in IGF2BP1 knockout A172 cells. At last, we show that miR-4500 levels are downregulated in human glioma tissues, correlating with IGF2BP1 upregulation. Together, we conclude that miR-4500 inhibits human glioma cell progression by targeting IGF2BP1.
Insights
MicroRNA-4500 (miR-4500) suppresses glioma progression by targeting Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1). Lower miR-4500 levels in glioma tissues correlate with higher IGF2BP1, confirming its role in tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Overexpression of Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is linked to glioma cell progression.
- MicroRNAs (miRNAs) represent a potential therapeutic strategy for silencing oncogenes like IGF2BP1.
Purpose of the Study:
- To investigate the potential of microRNA-4500 (miR-4500) to silence IGF2BP1 in glioma cells.
- To elucidate the role of the miR-4500/IGF2BP1 axis in glioma cell behavior and its clinical relevance.
Main Methods:
- Bioinformatic analysis to predict miR-4500 targeting of IGF2BP1 3'-untranslated region (3'-UTR).
- In vitro experiments involving ectopic miR-4500 overexpression and inhibition in A172 and primary human glioma cells.
- CRISPR/Cas9 gene editing to knock out IGF2BP1 in A172 cells.
- Analysis of IGF2BP1 and its target genes (Gli1, IGF2, c-Myc) expression.
- Assessment of glioma cell proliferation, survival, migration, and invasion.
- Correlation analysis of miR-4500 and IGF2BP1 levels in human glioma tissues.
Main Results:
- Bioinformatic analysis confirmed miR-4500's putative targeting of the IGF2BP1 3'-UTR.
- Ectopic overexpression of wild-type miR-4500 (but not mutant) downregulated IGF2BP1 and its targets (Gli1, IGF2, c-Myc) in glioma cells.
- miR-4500 overexpression inhibited glioma cell growth, survival, proliferation, migration, and invasion.
- miR-4500 inhibition increased IGF2BP1 expression and promoted glioma cell progression.
- IGF2BP1 knockout inhibited A172 cell progression, and miR-4500's effects were abolished in these cells.
- Human glioma tissues showed downregulated miR-4500 and upregulated IGF2BP1.
Conclusions:
- miR-4500 functions as a tumor suppressor in human glioma by directly targeting and downregulating IGF2BP1.
- The miR-4500/IGF2BP1 axis is a critical regulator of glioma cell progression.
- miR-4500 represents a potential therapeutic target for glioma treatment.
More Related Videos
10:48Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
Published on: April 12, 2015
07:19Identifying Targets of Human microRNAs with the LightSwitch Luciferase Assay System using 3'UTR-reporter Constructs and a microRNA Mimic in Adherent Cells
Published on: September 28, 2011
Related Concept Videos
MicroRNAs
MicroRNAs
Feedback Inhibition
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Enzyme Inhibition
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...